Barely Significant
← all phrases

“indeterminate significance”

138 sentences · 138 papers · 164 search hits before verification · confirmed specimen

Sighted at

p=0.08

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

Alteration in Malignancy Rate with the Introduction of Non-Invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP) Since significant portions of noninvasive FVPTCs are categorized as atypia of indeterminate significance (AUS), suspicious for follicular neoplasm (SFN) and suspicious for malignancy (SUS), the greatest impact of this new nomenclature was expected in these categories [ 6 , 16 , 17 ].
In terms of cytological diagnosis, 13 (1.6%) samples were classified as nondiagnostic, 202 (24.6%) as benign, 147 (17.9%) as indeterminate (142 atypia of indeterminate significance/follicular lesion of indeterminate significance AUS/FLUS, and 5 follicular neoplasm/suspicious for follicular neoplasm FN/SFN), 92 (11.2%) as suspicious for malignancy (SUSP), and 368 (44.8%) as malignant.
Our predictive model based on conventional US features and BRAF V600E shows that combining capsule contact, C-TIRADS, and BRAF V600E mutations can assist in distinguishing the benignity and malignancy of thyroid nodules with indeterminate significance.
Cytological diagnosis from FNA samples typically follows the Bethesda System for Reporting Thyroid Cytopathology (BSRTC), categorizing nodules into clearly benign (Bethesda II) and malignant (Bethesda VI), as well as categories with indeterminate significance, notably Bethesda III (atypia of undetermined significance [AUS]) and Bethesda IV (follicular neoplasm [FN]) [ 4 , 5 ].
We analyzed 2 groups of variants found in 8 genes with definitive evidence for HCM ( 3 ): sarcomeric variants P/LP specifically for HCM (SARC-HCM-P/LP) and rare sarcomeric variants of indeterminate significance (SARC-IND) with the potential to cause HCM, dilated cardiomyopathy (DCM), or have little impact on cardiomyopathy risk.
The term clonal hematopoiesis of indeterminate significance (CHIP) was introduced to describe individuals with a hematologic malignancy-associated somatic mutation in peripheral blood or bone marrow cells but without any other diagnostic criteria for a hematologic malignancy. 107 CHIP must be distinguished from myelodysplastic syndromes (MDS) by the absence
Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies.
Mediterr J Hematol Infect Dis · 2022 · PMC9448266
The rest of the categories (Bethesda class I – inadequate; Bethesda class III – atypical cells or follicular cells of indeterminate significance; Bethesda class IV – follicular neoplasm; and Bethesda class V – suspicious for malignancy) were considered non-diagnostic and were included in the final analysis only if surgical histopathology was available.